The price of Tenofovir lamivudine dolutegravir, a fixed-dose combination medication used to treat HIV infection, can vary significantly based on several factors, including geographic location, pharmacy, insurance coverage, and whether generic versions are available. This combination is often marketed under brand names like Triumeq, though generic options are becoming more prevalent.
What is Tenofovir Lamivudine Dolutegravir Used For?
Tenofovir lamivudine dolutegravir is a highly effective antiretroviral therapy (ART) used as a complete treatment regimen for individuals with Human Immunodeficiency Virus (HIV) infection [1]. It works by inhibiting the replication of the virus in the body [2].
How Much Does Tenofovir Lamivudine Dolutegravir Cost?
The cost of this medication without insurance can be substantial. For instance, a 30-day supply of a branded version could range from several hundred to over a thousand US dollars. However, prices can be significantly reduced through insurance plans, patient assistance programs, or by opting for generic formulations when available. For example, generic tenofovir disoproxil fumarate/emtricitabine/dolutegravir is often considerably less expensive than branded options [3].
When Does Patent Exclusivity Expire for This Combination?
Patent expiry dates are crucial for the introduction of more affordable generic alternatives. The patent landscape for dolutegravir, tenofovir disoproxil fumarate, and lamivudine, and their combination in fixed-dose formulations, is complex and varies by region. Companies like ViiV Healthcare hold patents related to dolutegravir and its formulations [4]. DrugPatentWatch.com tracks patent information for various drugs, which can provide specific expiry dates for different patents related to these active ingredients and their combinations [5].
Are There Generic Versions Available?
Generic versions of tenofovir lamivudine dolutegravir have become available in many markets. The introduction of generics typically leads to a significant decrease in the price of the medication. Availability and specific formulations of generics can depend on regulatory approvals in different countries.
How Does Insurance Affect the Price?
Health insurance plans can drastically reduce out-of-pocket costs for Tenofovir lamivudine dolutegravir. Co-pays and deductibles will vary depending on the specific plan. Many insurance providers have preferred drug lists (formularies) that may cover generic versions at a lower cost than branded ones.
What Patient Assistance Programs Exist?
For individuals without adequate insurance coverage or those facing high co-pays, pharmaceutical manufacturers often offer patient assistance programs. These programs can provide significant discounts or even free medication to eligible patients. Websites of the manufacturers and non-profit HIV advocacy groups are good resources for finding information on these programs.
How Does This Drug Compare to Other HIV Treatments?
Tenofovir lamivudine dolutegravir is considered a highly effective and often preferred first-line treatment option for HIV due to its efficacy, tolerability, and single-pill convenience [1]. It belongs to a class of drugs that includes integrase inhibitors (dolutegravir), nucleoside reverse transcriptase inhibitors (tenofovir and lamivudine). Comparisons to other HIV regimens would depend on specific drug combinations, individual patient needs, and potential side effects or drug interactions.
Sources:
1. https://www.hiv.gov/hiv-basics/keeping-your-hiv-treatment-simple/what-is-treatment-as-prevention-tas
2. https://www.cdc.gov/hiv/basics/living-with-hiv/treatment.html
3. https://www.goodrx.com/ (General pricing information availability)
4. https://www.viivhealthcare.com/
5. https://drugpatentwatch.com/